While protein corona formation can sometimes lower toxicity, it may also interfere with liposome functionality, highlighting ...

The Company’s second product, BP1002, which targets the Bcl-2 protein, is being evaluated for the treatment of blood cancers and solid tumors, including acute myeloid leukemia. In addition, an IND ...